Abstract
There is now considerable evidence for the presence of dopamine receptors in peripheral tissues, as is documented throughout this volume. There has been, however, a reluctance to accept the possibility of a peripheral dopaminergic neuronal system to innervate these receptors for several reasons. Traditionally, students are taught that the autonomic nervous system is composed of only two types of neurons, cholinergic and noradrenergic. It is difficult to break with tradition. Dopamine is present in autonomic nerves, and it represents about 5–10% of the norepinephrine content. Therefore, it is assumed to be solely a precursor for norepinephrine synthesis and not a neurotransmitter. We should recall that dopamine in the spinal cord represents about 5–10% of the norepinephrine, and, until recently, it was considered to be only a precursor for norepinephrine. There is now a vast literature on the presence of dopaminergic neurons in the cord together with speculation about their possible physiological role (Commissiong et al., 1978; Gentleman et al, 1981; Commissiong and Neff, 1979). What percentage of dopamine should be found in a nerve or tissue to raise suspicion that dopaminergic neurons are present within a structure? Is the percentage of dopamine present meaningful if it is concentrated in a few neurons and nerve endings? Moreover, the quantity of amine stored in a nerve ending may not be as important as its rate of formation and release onto receptors.
Keywords
- Dopaminergic Neuron
- Dopamine Receptor
- Sympathetic Ganglion
- Superior Cervical Ganglion
- Ganglionic Transmission
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexander, R. W., Gill, T. R., Jr., Yamabe, H., Lovenberg, W., and Keiser, H. R., 1974, Effects of dietary sodium and acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man, J. Clin. Invest. 54:194–200.
Altura, B. M., Gebrewold, A., and Lassoff, S., 1980, Biphasic responsiveness of rat pial arterioles to dopamine: Direct observations on the microcirculation, Br. J. Pharmacol. 69:543–544.
Attie, M. F., Brown, E. M., Gardner, D. G., Spiegel, A. M., and Aurbach, G. D., 1980, Characterization of the dopamine-responsive adenylate cyclase of bovine parathyroid cells and its relationship to parathyroid hormone secretion, Endocrinology 107:1776–1781.
Badia, A., Bermejo, P., and Jane, F., 1982, Pre-and postsynaptic effects of Sulpiride in the rat isolated vas deferens, J. Pharm. Pharmacol. 34:266–268.
Ball, S. G., Oats, N. S., and Lee, M. R., 1978, Urinary dopamine in man and rat: Effects of inorganic salts on dopamine excretion, Clin. Sci. Mol. Med. 55:167–173.
Beck, L., Pollard, A. A., Kayaalp, S. O., and Weiner, L. M., 1966, Sustained dilatation elicited by sympathetic nerve stimulation, Fed. Proc. 25:1596–1606.
Bell, C, 1982a, Dopamine as a postganglionic autonomic neurotransmitter, Neuroscience 7:1–8.
Bell, C, 1982b, Benztropine-induced Prolongation of responses to vasodilator nerve Stimulation in the canine paw pad, Br. J. Pharmacol. 76:231–233.
Bell, C, and Gillespie, J. S., 1981, Dopamine and noradrenaline levels in peripheral tissues of several mammalian species, J. Neurochem. 36:703–706.
Bell, C, and Lang, W. J., 1979, Evidence for dopaminergic vasodilator innervation of the canine paw pad, Br. J. Pharmacol. 67:337–343.
Bell, C, and Muller, B. D., 1982, Absence of dopamine-β-hydroxylase in some catecholamine-containing sympathetic ganglion cells of the dog: Evidence for dopaminergic autonomic neurones, Neurosci. Lett. 31:31–35.
Bell, C, Lang, W. J., and Laska, F., 1978a, Dopamine-containing vasomotor nerves in the dog kidney, J. Neurochem. 31:77–83.
Bell, C, Lang, W. J., and Laska, F., 1978b, Dopamine-containing axons supplying the arterio-venous anastomoses of the canine paw pad, J. Neurochem. 31:1329–1333.
Bjorklund, A., Cegrell, L., Falck, B., Ritzin, M., and Rosengren, E., 1970, Dopaminecontaining cells in sympathetic ganglia, Acta Physiol. Scand. 78:334–338.
Boadle-Biber, M. C, and Roth, R. H., 1975, Formation of dopamine and noradrenaline in rat vas deferens: Comparison with guinea pig vas deferens, Br. J. Pharmacol. 55:73–78.
Brodde, O. E., 1982, Vascular dopamine receptors: Demonstration and characterization by in vitro studies, Life Sci. 31:289–306.
Brown, E. M., Carroll, R. J., and Aurbach, G. D., 1977, Dopaminergic Stimulation of cyclic AMP accumulation and parathyroid hormone release from dispersed bovine parathyroid cells, Proc. Natl. Acad. Sci. U.S.A. 74:4210–4213.
Brown, E. M., Attie, M. F., Reen, S., Gardner, D. G., Kebabian, J., and Aurbach, G. D., 1980, Characterization of dopaminergic receptors in dispersed bovine parathyroid cells, Mol. Pharmacol. 18:335–340.
Carey, R. M., Thorner, M. O., and Ortt, E. M., 1979, Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone, J. Clin. Invest. 63:727–735.
Carlsson, A., and Lindqvist, M., 1963, Effect of chlorpromazine or haloperidol or formation of 3-methoxytyramine and normetanephrine in mouse brain, Acta Pharmacol. Toxicol. (Kbh.) 20:140–144.
Cavero, I., Massingham, R., and Lefevre-Borg, F., 1982a, Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I. Subclassification and functional description, Life Sci. 31:939–948.
Cavero, I., Massingham, R., and Lefevre-Borg, F., 1982b, Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part II. Sites and mechanisms of action of dopamine receptor agonists, Life Sci. 31:1059–1069.
Collins, G. G., and West, G. B., 1968, The release of 3H-dopamine from the isolated rabbit ileum, Br. J. Pharmacol. 34:514–522.
Commissiong, J. W., and Neff, N. H., 1979, Current Status of dopamine in the mammalian spinal cord, Biochem. Pharmacol. 28:1569–1573.
Commissiong, J. W., Galli, C. L., and Neff, N. H., 1978, Differentiation of dopaminergic and noradrenergic neurons in rat spinal cord, J. Neurochem. 30:1095–1099.
Costa, E., and Neff, H. H., 1966, Isotopic and non-isotopic measurements of the rate of catecholamine biosynthesis, in: Biochemistry and Pharmacology of the Basal Ganglia (E. Costa, L. J. Cote, and M. D. Yahr, eds.), Raven Press, New York, pp. 141–156.
Dahlstrom, A., and Fuxe, K., 1965, Evidence of the existence of an outflow of noradrenaline nerve fibers in the ventral roots of the rat spinal cord, Experientia 21:409–410.
Dinerstein, R. J., Vannice, J., Henderson, R. C, Roth, L. J., Goldberg, L. I., and Hoffmann, P. C, 1979, Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney, Science 205:497–499.
Dunn, M. G., and Bosmann, B. H., 1981, Peripheral dopamine receptor identification: Properties of a specific dopamine receptor in the rat adrenal zona glomerulosa, Biochem. Biophys. Res. Commun. 99:1081–1087.
Edvinsson, L., Hardebo, J. E., McCulloch, J., and Owman, C, 1978, Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels, Acta. Physiol. Scand. 104:349–359.
Eranko, O., and Harkonen, M., 1963, Histochemical demonstration of fluorogenic amines in the cytoplasm of sympathetic ganglion cells of the rat, Acta Physiol. Scand. 58:285–286.
Furuta, Y., Hashimoto, K., Iwatsuki, K., and Takeuchi, 0., 1973, Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs, Br. J. Pharmacol. 47:77–84.
Gentleman, S., Parenti, M., Commissiong, J. W., and Neff, N. H., 1981, Dopamine-activated adenylate cyclase of spinal cord: Supersensitivity following transection of the cord, Brain Res. 210:271–275.
George, D. T., and Rayfield, E. J., 1974, L-Dopa induced plasma glucagon release, J. Clin. Endocrinol. Metab. 39:618–621.
Goldberg, L. I., 1972, Cardiovascular and renal actions of dopamine: Potential clinical applications, Pharmacol. Rev. 24:1–29.
Goldberg, L. I., Volkman, P. H., and Kohli, J. D., 1978, A comparison of the vascular dopamine receptor with other dopamine receptors, Annu. Rev. Pharmacol. Toxicol. 18:57–79.
Hadjiconstantinou, M., Potter, P. E., and Neff, N. H., 1982, Transsynaptic modulation via muscarinic receptors of serotonin-containing SIF cells of superior cervical ganglion, J. Neurosci. 2:1836–1839.
Head, R. J., and Berkowitz, B. A., 1979, Concentration and function of dopamine in normal and diseased blood vessels, in: Peripheral Dopamine Receptor (J. L. Imbs and J. Schwartz, eds.), Pergamon Press, Oxford, pp. 173–181.
Head, R. J., Hjelle, J. T., Jarrott, B., Berkowitz, B., Cardinale, G., and Spector, S., 1980, Isolated brain microvessels: Preparation, morphology, histamine and catecholamine contents, Blood Vessels 17:173–186.
Heilman, R. D., and Lum, B. K., 1971, Studies on the intestinal relaxation produced by dopamine, J. Pharmacol. Exp. Ther. 178:63–72.
Hokfelt, T., Kellerth, J. O., Nilsson, G., and Pernow, B., 1975, Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons, Brain Res. 100:232–252.
Iwatsuki, K., and Chiba, S., 1980, Comparative study of the secretory response to dopamine and seven amino acid conjugated derivatives on the blood-perfused canine pancreas, Jpn. J. Pharmacol. 30:621–627.
Karoum, F., Garrison, C. K., Neff, N. H., and Wyatt, R. J., 1977, Transsynaptic modulation of dopamine metabolism in the rat superior cervical ganglion, J. Pharmacol. Exp. Ther. 201:654–661.
Karoum, F., Speciale, S. G., Jr., and Neff, N. H., 1980, 3,4-Dihydroxyphenylacetic acid content of sympathetic ganglia as a possible biochemical indicator of small intensely fluorescent cell participation in ganglionic transmission, Biochem. Pharmacol. 29:118–119.
Katz, D. M., Markey, K. A., Goldstein, M., and Black, I. B., 1982, Expression of catecholaminergic characteristic by peripheral sensory ganglion cells in the normal adult rat in vivo, Soc. Neurosci. Abstr. 8:8.
Kebabian, J. W., and Calne, D. B., 1979, Multiple receptors for dopamine, Nature 277:93–96.
Kojima, H., Suetake, K., Yokoo, H., Anraku, S., Inanago, K., Higashi, H., Nishi, S., Yamamoto, T., and Ochi, J., 1981, Dopamine-containing cells in rabbit nodose ganglia, Experientia 37:1332–1333.
Koslow, S. H., Bjegovic, M., and Costa, E., 1975, Catecholamines in sympathetic ganglia of rat: Effects of dexamethasone and reserpine, J. Neurochem. 24:277–281.
Lackovic, Z., and Neff, N. H., 1980, Evidence for the existence of peripheral dopaminergic neurons, Brain Res. 193:289–292.
Lackovic, Z., Kleinman, J., Karoum, F., and Neff, N. H., 1981, Dopamine and its metabolites in human peripheral nerves: Is there a widely distributed system of peripheral dopaminergic nerves? Life Sci. 29:917–922.
Lackovic, Z., Relja, M., and Neff, N. H., 1982, Catabolism of endogenous dopamine in peripheral tissues: Is there an independent role for dopamine in peripheral neurotransmission? J. Neurochem. 38:1453–1458.
Libet, B., 1977, The role SIF-cells play in ganglionic transmission, Adv. Biochem. Psychopharmacol. 16:541–546.
Libet, B., and Owman, C, 1974, Concomitant changes in formaldehyde-induced fluorescence of dopamine interneurons and in slow inhibitory postsynaptic potentials of the rabbit superior cervical ganglion, induced by stimulation of the preganglionic nerve or by a muscarinic agent, J. Physiol. (Lond.) 237:635–662.
Libet, B., and Tosaka, T., 1970, Dopamine as a synaptic transmitter and modulator in sympathetic ganglia; a different mode of synaptic action, Proc. Natl. Acad. Sci. U.S.A. 67:667–673.
Lokhandwala, M. F., 1979, Presynaptic receptor Systems on cardiac sympathetic nerves, Life Sci. 24:1823–1832.
Long, J. P., Heintz, S., Cannon, J. G., and Kim, J., 1975, Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine, J. Pharmacol. Exp. Ther. 192:336–342.
Lutold, B. E., Karoum, F., and Neff, N. H., 1979. Activation of rat sympathetic ganglia SIF cell dopamine metabolism by muscarinic agonists, Eur. J. Pharmacol. 54:21–26.
Matthews, M. R., 1980, Ultrastructural studies relevant to the possible funetions of small granule-containing cells in the rat superior cervical ganglion, Adv. Biochem. Psychopharmacol. 25:77–86.
McKenna, T. J., Island, D. P., Nicholson, W. E., and Liddle, G. W., 1979, Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells, J. Clin. Invest. 64:287–291.
Morgunov, N., and Baines, A. D., 1981, Renal nerves and catecholamine excretion, Am. J. Physiol. 240:F75–F81.
Mukhopadhyay, A. K., and Weisbrodt, N., 1977, Effect of dopamine on esophageal motor function, Am. J. Physiol. 232:E19–E24.
Murthy, V. V., Gilbert, J. C, Goldberg, L. I., and Kuo, J. F., 1976, Dopamine-sensitive adenylate cyclase in canine renal artery, J. Pharm. Pharmacol. 28:567–571.
Nagy, J. I., and Hunt, S. P., 1982, Fluoride-resistant acid phosphatase-containing neurones in dorsal root ganglia are separate from those containing substance P or somatostatin, Neuroscience 7:89–97.
Nakajima, T., Naitoh, F., and Kuruma, I., 1977, Dopamine-sensitive adenylate cyclase in the rat kidney particulate preparation, Eur. J. Pharmacol. 41:163–169.
Nielsen, K. C, and Owman, C, 1967, Adrenergic innervation of pial arteries related to the circle of Willis of the cat, Brain Res. 6:773–776.
Norbiato, G., Bevilacqua, M., Raggi, U., Micossi, P., and Moroni, C, 1977, Metoclopramide increases plasma aldosterone concentration in man, J. Clin. Endocrinol. Metab. 45:1313–1316.
Noth, R. H., McCallum, R. W., Contino, C, and Havelick, J., 1980, Tonic dopaminergic suppression of plasma aldosterone, J. Clin. Endocrinol. Metab. 51:64–69.
Owman, C, and Santini, M., 1966, Adrenergic nerves in spinal ganglia of the cat, Acta Physiol. Scand. 68:127–128.
Price, J., and Mudge, A. W., 1983, A subpopulation of rat dorsal root ganglion neurones in catecholaminergic, Nature 301:241–243.
Relja, M., Lackovic, Z., and Neff, N. H., 1982, Evidence for the presence of dopaminergic receptors in vas deferens, Life Sci. 31:2571–2575.
Rolewicz, T. F., and Zimmerman, B. G., 1972, Peripheral distribution of cutaneous sympathetic vasodilator system, Am. J. Physiol. 223:939–943.
Shima, S., Kawashima, Y., Hirai, M., and Asakura, M., 1980, Effect of adrenergic Stimulation on adenylate cyclase activity in rat prostate, Biochem. Biophys. Acta 628:255–262.
Simon, A., and Van Maanen, E. F., 1976, Dopamine receptors and dopaminergic nerves in vas deferens of the rat, Arch. Int. Pharmacodyn. Ther. 222:4–15.
Sowers, J. R., Stern, N., and Taylor, I. L., 1982, Evidence for dopaminergic modulation of pancreatic Polypeptide secretion in man, Life Sci. 31:2971–2975.
Spitz, I. M., Zylber, E., Jersky, J., and Leroith, D., 1979, Atropine suppression of basal and metoclopramide-induced human pancreatic Polypeptide secretion in man, Metabolism 28:527–530.
Stephenson, R. K., Sole, M. J., and Baines, A. D., 1982, Neural and extraneural catecholamine produetion by rat kidneys, Am. J. Physiol. 242:F261–F266.
Suzuki, Y., Okada, T., Shibuya, M., Mutsuga, N., Kageyama, N., and Hidaka, H., 1983, Regional distribution of dopamine and norepinephrine in canine cerebral arteries—Effect of pre-or postganglionic sympathetic denervation, Brain Res. 258:53–58.
Tayo, F. M., 1979, Potentiation of dopamine-induced contractions of the rat vas deferens by low concentrations of its antagonists, Arch. Int. Pharmacodyn. Ther. 241:190–196.
Tayo, F. M., 1981, Prejunctional inhibitory dopamine receptors in the rat isolated vas deferens, Arch. Int. Pharmacodyn. Ther. 254:28–37.
Valenzuela, J. E., 1976, Dopamine as a possible neurotransmitter in gastric relaxation, Gastroenterology 71:1019–1022.
Verhofstad, A. A. J., Steinbusch, H. W. M., Penke, B., Varga, J., and Joosten, H. W. J., 1981, Serotonin-immunoreactive cells in the superior cervical ganglion of the rat. Evidence for the existence of separate Serotonin-and catecholamine-containing small ganglionic cells, Brain Res. 212:39–49.
Wamsley, J. K., Black, A. C, Jr., Redick, J. A., West, J. R., and Williams, T. H., 1978, SIF cells, cyclic AMP responses, and catecholamines of guinea pig superior cervical ganglion, Brain Res. 156:75–82.
Williams, T. H., Chiba, T., Black, A. C., Jr., Bhalla, R. C, and Jew, J., 1976, Species variation in SIF cells of superior cervical ganglia: Are there two functional types? in: SIF Cells: Structure and Function of the Small Intensely Fluorescent Sympathetic Cells (O. Eranko, ed.), Fogarty International Center Proceedings No. 30, pp. 143–162. DHEW Publication No (NIH) 76-942, Washington, D. C.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Neff, N.H., Hadjiconstantinou, M., Lackovic, Z. (1984). Dopamine. In: Poste, G., Crooke, S.T. (eds) Dopamine Receptor Agonists. New Horizons in Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0310-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0310-8_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0312-2
Online ISBN: 978-1-4757-0310-8
eBook Packages: Springer Book Archive